Autopsy report · NCT04853043
Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer
Cause of deathSlow enrollment, also funding or business
“PI Determination - Slow recruitment, funding concerns, poor response to treatment”
Life of this trial
- Registered 7 months before it started.
- Ran for about 2 years 6 months before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Conditions
- Colorectal Cancer
- Interventions
- Cetuximab
- Participants
- 7
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Aliskiren and Renin Inhibition in Diastolic Heart Failure
“Difficulty in recruiting patients and then the PI left the institution” - Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period
“No recruitment occurred and the PI stopped the study” - Pre-post Spinal Popliteal Block
“Retrospective study that the PI decided not to proceed with” - Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
“PI left institution, end of funding, clinic relocation, recruitment issues” - Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice
“PI has encountered recruitment challenges.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.